News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Sareum Ltd. Says Reaches Key Milestones In Collaboration With Schering AG
June 8, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Sareum Holdings PLC, the specialist structure-based drug discovery business said it has achieved key milestones in its collaboration with Schering AG and has received success milestone payments.
Twitter
LinkedIn
Facebook
Email
Print
Alliances
Europe
MORE ON THIS TOPIC
Immunology and inflammation
Roche bets up to $1B to advance next-gen bispecifics with Dualitas
September 17, 2026
·
1 min read
·
Tristan Manalac
Layoff Tracker
Sionna says good-bye to 46% of staffers, including exec
September 16, 2026
·
93 min read
·
BioSpace Editorial Staff
Funding
Sling catches $123M series C for thyroid eye disease pill
September 16, 2026
·
2 min read
·
Tristan Manalac
FDA
FDA hears input on psychedelics, PDUFA, lung cancer’s next-gen therapies boost survival
September 16, 2026
·
1 min read
·
Jef Akst
